Searched over 200M research papers
10 papers analyzed
These studies suggest that while cancer mortality rates have generally declined since 1991, with significant reductions in lung cancer and melanoma deaths, the incidence of certain cancers like breast, prostate, and uterine corpus cancers is rising, and there are disparities in mortality rates based on race and socioeconomic status.
20 papers analyzed
In 2020, the global cancer burden was substantial, with an estimated 19.3 million new cancer cases and nearly 10 million cancer deaths worldwide. Female breast cancer emerged as the most commonly diagnosed cancer, accounting for 2.3 million new cases, surpassing lung cancer, which had 2.2 million new cases. Lung cancer, however, remained the leading cause of cancer death, responsible for 1.8 million deaths, followed by colorectal, liver, and stomach cancers.
Back in 2002, the global cancer landscape was different, with 10.9 million new cases and 6.7 million deaths. Lung cancer was the most commonly diagnosed cancer and the leading cause of cancer death, followed by stomach and liver cancers. The most prevalent cancer was breast cancer, with 4.4 million survivors up to five years post-diagnosis.
In the United States, 1,958,310 new cancer cases and 609,820 cancer deaths are projected for 2023. Notably, prostate cancer incidence increased by 3% annually from 2014 to 2019, while lung cancer incidence in women decreased at half the pace of men. Despite the pandemic, the cancer death rate continued to decline, contributing to a 33% overall reduction since 1991, averting an estimated 3.8 million deaths.
In 2022, the United States saw 1,918,030 new cancer cases and 609,360 cancer deaths. Lung cancer remained the leading cause of cancer death, with approximately 350 deaths per day. The incidence of female breast cancer continued to rise slowly, while prostate cancer incidence remained stable. However, the proportion of advanced prostate cancer cases increased significantly.
In 2020, the United States projected 1,806,590 new cancer cases and 606,520 cancer deaths. The cancer death rate had been declining since 1991, resulting in a 29% overall reduction by 2017, translating to 2.9 million fewer cancer deaths. This progress was driven by long-term declines in death rates for lung, colorectal, breast, and prostate cancers.
In 2014, the United States projected 1,665,540 new cancer cases and 585,720 cancer deaths. The combined cancer death rate had been declining for two decades, from a peak of 215.1 per 100,000 population in 1991 to 171.8 in 2010, avoiding approximately 1,340,400 cancer deaths during this period.
Cancer remains a significant global health challenge, with varying incidence and mortality rates across different regions and time periods. While the overall cancer death rate has been declining in the United States, driven by reductions in smoking and advancements in early detection and treatment, the incidence of certain cancers like prostate and breast cancer continues to rise. Global efforts to improve cancer prevention, early detection, and treatment are crucial to further reduce the cancer burden worldwide.
Most relevant research papers on this topic